Business
LGC Capital, Creso Pharma and Baltic Beer Company Ltd sign Binding Letter of Intent to develop cannabis and hemp derived alcoholic and non-alcoholic beverages
LGC Capital, Creso Pharma and Baltic Beer Company Ltd sign Binding Letter of Intent to dev...
About this update from Elixxer Ltd.
[{"type":"text","content":"\n\n\n\nLGC Capital, Creso Pharma and Baltic Beer Company Ltd sign Binding Letter of Intent to develop cannabis and hemp derived alcoholic and non-alcoholic beverages\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTREAL, Nov. 29, 2017\n\n\n\nHighlights:\n\n\nLGC Capital has signed a binding letter of intent with Creso Pharma Ltd and Baltic Beer Company Ltd\nThe new joint venture will create a bespoke portfolio of unique cannabis- and hemp-derived alcoholic and non-alcoholic beverages\nCreso Pharma to expand its product offering into the growing edible and lifestyle markets\nResearch and development work already underway in Switzerland, Estonia and the United Kingdom\n\n\nMONTREAL, Nov. 29, 2017 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) (\"LGC\") is pleased to announce that LGC, Creso Pharma Limited (Australia and Switzerland) and Baltic Beer Company Ltd (UK), the home of the multi-award winning Viru Beer, have signed a Binding Letter of Intent to develop and market a bespoke portfolio of cannabis- and hemp-derived alcoholic and non-alcoholic beverages containing various ingredients, seeds, extracts and terpenes from hemp and cannabis plants.\n\nThe new joint venture company will include the following board members: Dr. Miri Halperin Wernli of Creso Pharma, John McMullen of LGC, and Alex Klaos of Baltic Beer Company Ltd, whose role will be to oversee the day-to-day operations of the new entity to ensure product development, growth targets and distribution reach are achieved.\n\nResearch and development work has already started in Switzerland, Estonia and the United Kingdom on a premium craft beer range containing unique terpenes mixes mimicking the terpenes of the cannabis plant. Terpenes are essential oils (organic compounds) found in plants that carry flavour and aroma.\n\nThe terpenes in the beer will carry the characteristic odour and fragrance of cannabis with the same taste and feel but will not contain THC or CBD or any other cannabinoids. The terpene mixes used to formulate the beers will have the smell and aroma of...